Pharmena Statistics

Total Valuation

Pharmena has a market cap or net worth of PLN 54.02 million. The enterprise value is 43.25 million.

Market Cap	54.02M
Enterprise Value	43.25M

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Pharmena has 11.14 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	11.14M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.54%
Owned by Institutions (%)	3.07%
Float	3.12M

Valuation Ratios

The trailing PE ratio is 1.86.

PE Ratio	1.86
Forward PE	n/a
PS Ratio	185.63
PB Ratio	4.37
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.30, with an EV/FCF ratio of -2.87.

EV / Earnings	1.49
EV / Sales	148.64
EV / EBITDA	1.30
EV / EBIT	1.30
EV / FCF	-2.87

Financial Position

The company has a current ratio of 11.75, with a Debt / Equity ratio of 0.01.

Current Ratio	11.75
Quick Ratio	11.31
Debt / Equity	0.01
Debt / EBITDA	0.00
Debt / FCF	-0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 1,175.10% and return on invested capital (ROIC) is 264.29%.

Return on Equity (ROE)	1,175.10%
Return on Assets (ROA)	63.38%
Return on Capital (ROIC)	264.29%
Revenue Per Employee	19,400
Profits Per Employee	1.93M
Employee Count	15
Asset Turnover	0.01
Inventory Turnover	0.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.35% in the last 52 weeks. The beta is 0.53, so Pharmena's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-17.35%
50-Day Moving Average	5.43
200-Day Moving Average	6.38
Relative Strength Index (RSI)	28.83
Average Volume (20 Days)	2,614

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmena had revenue of PLN 291,000 and earned 29.00 million in profits. Earnings per share was 2.60.

Revenue	291,000
Gross Profit	254,000
Operating Income	33.28M
Pretax Income	34.09M
Net Income	29.00M
EBITDA	33.14M
EBIT	33.28M
Earnings Per Share (EPS)	2.60

Full Income Statement

Balance Sheet

The company has 10.92 million in cash and 156,000 in debt, giving a net cash position of 10.77 million or 0.97 per share.

Cash & Cash Equivalents	10.92M
Total Debt	156,000
Net Cash	10.77M
Net Cash Per Share	0.97
Equity (Book Value)	12.36M
Book Value Per Share	1.11
Working Capital	11.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.97 million and capital expenditures -128,000, giving a free cash flow of -15.09 million.

Operating Cash Flow	-14.97M
Capital Expenditures	-128,000
Free Cash Flow	-15.09M
FCF Per Share	-1.36

Full Cash Flow Statement

Margins

Gross margin is 87.29%, with operating and profit margins of 11,435.40% and 9,964.60%.

Gross Margin	87.29%
Operating Margin	11,435.40%
Pretax Margin	11,715.12%
Profit Margin	9,964.60%
EBITDA Margin	11,387.97%
EBIT Margin	11,435.40%
FCF Margin	-5,186.60%

Dividends & Yields

This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 17.53%.

Dividend Per Share	0.85
Dividend Yield	17.53%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	32.65%
Buyback Yield	n/a
Shareholder Yield	17.53%
Earnings Yield	53.68%
FCF Yield	-27.94%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pharmena has an Altman Z-Score of 47.16.

Altman Z-Score	47.16
Piotroski F-Score	n/a